Antiepileptic Drugs in Non-Epilepsy Disorders
暂无分享,去创建一个
[1] C. Cepeda,et al. Neurons Recorded from Pediatric Epilepsy Surgery Patients with Cortical Dysplasia , 2000, Epilepsia.
[2] P. Keck,et al. Valproate oral loading in the treatment of acute mania. , 1993, The Journal of clinical psychiatry.
[3] H. Diener,et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[4] K. Nocka,et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Moshé,et al. Nonepileptic uses of antiepileptic drugs in children and adolescents. , 2006, Pediatric neurology.
[6] G. Winterer,et al. Valproate and the symptomatic treatment of schizophrenia spectrum patients. , 2000, Pharmacopsychiatry.
[7] P. Jobe. Affective Disorder and Epilepsy Comorbidity: Implications for Development of Treatments, Preventions and Diagnostic Approaches , 2004, Clinical EEG and neuroscience.
[8] F. Fonnum,et al. The acute effect of valproate on cerebral energy metabolism in mice , 2001, Epilepsy Research.
[9] M. Moskowitz,et al. The Actions of Valproate and Neurosteroids in a Model of Trigeminal Pain , 1996, Headache.
[10] G. Thickbroom,et al. Gabapentin can improve postural stability and quality of life in primary orthostatic tremor , 2005, Movement disorders : official journal of the Movement Disorder Society.
[11] L. Provinciali,et al. Efficacy of Topiramate and Valproate in Chronic Migraine , 2005, Clinical neuropharmacology.
[12] D. Johnston,et al. Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites , 2002, Nature Neuroscience.
[13] K. Bushara,et al. The effect of levetiracetam on essential tremor , 2005, Neurology.
[14] A. Nierenberg,et al. Inositol augmentation of lithium or valproate for bipolar depression. , 2006, Bipolar disorders.
[15] Jon S. C. Yu,et al. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate , 2010, Journal of neurochemistry.
[16] E. Perucca,et al. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI) , 2002, Epilepsy Research.
[17] A. Sinclair,et al. Alfuzosin and the venous reflex response: studies in normal subjects. , 1989, British journal of clinical pharmacology.
[18] P. Patsalos,et al. The New Generation of GABA Enhancers , 2001, CNS drugs.
[19] J. Huguenard,et al. Chronic Valproic Acid Treatment Triggers Increased Neuropeptide Y Expression and Signaling in Rat Nucleus Reticularis Thalami , 2006, The Journal of Neuroscience.
[20] E. Perucca,et al. An Introduction to Antiepileptic Drugs , 2005, Epilepsia.
[21] Peter K. Leiberich,et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. , 2005, The International journal of eating disorders.
[22] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[23] Michael A. Rogawski,et al. Diverse mechanisms of antiepileptic drugs in the development pipeline , 2006, Epilepsy Research.
[24] B. Fiebich,et al. Valproic acid inhibits substance P‐induced activation of protein kinase C epsilon and expression of the substance P receptor , 2003, Journal of neurochemistry.
[25] F. H. Lopes da Silva,et al. Epileptogenesis and rational therapeutic strategies , 2006, Acta neurologica Scandinavica.
[26] G. McCleane. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. , 1999, Anesthesia and analgesia.
[27] M. Okada,et al. Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors , 2005, Epilepsy Research.
[28] S. Silberstein. Topiramate in Migraine Prevention , 2005, Headache.
[29] Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis , 2003, Molecular microbiology.
[30] C. Nemeroff,et al. The role of GABA in the pathophysiology and treatment of anxiety disorders. , 2003, Psychopharmacology bulletin.
[31] P. Striano,et al. Levetiracetam for cerebellar tremor in multiple sclerosis , 2006, Journal of Neurology.
[32] Joseph Jankovic,et al. An Open-Label Pilot Study of Levetiracetam for Essential Tremor , 2004, Clinical neuropharmacology.
[33] S. Sheth,et al. A controlled study comparing visual function in patients treated with vigabatrin and tiagabine , 2003 .
[34] H. Gendelman,et al. Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis , 2003, The Journal of Neuroscience.
[35] S. Williams,et al. Nuclear Magnetic Resonance Detection of Increased Cortical GABA in Vigabatrin‐Treated Rats In Vivo , 1994, Epilepsia.
[36] A. Handforth,et al. Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor , 2004, Movement disorders : official journal of the Movement Disorder Society.
[37] J. Tiihonen,et al. Topiramate add-on in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial. , 2005, The Journal of clinical psychiatry.
[38] H. Manji,et al. Mood stabilizers target cellular plasticity and resilience cascades , 2005, Molecular Neurobiology.
[39] San-jue Hu,et al. Effects of gabapentin on spontaneous discharges and subthreshold membrane potential oscillation of type A neurons in injured DRG , 2005, Pain.
[40] Michael A Rogawski,et al. Astrocytes get in the act in epilepsy , 2005, Nature Medicine.
[41] H. Miwa,et al. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. , 2005, Parkinsonism & related disorders.
[42] J. Oakman,et al. An open trial of topiramate in the treatment of generalized social phobia. , 2004, The Journal of clinical psychiatry.
[43] S. Landy. Migraine throughout the life cycle , 2004, Neurology.
[44] Jon S. C. Yu,et al. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate , 2005, Journal of neurochemistry.
[45] A. Kanner. Depression in Epilepsy: A Neurobiologic Perspective , 2005, Epilepsy currents.
[46] G. S. Connor,et al. A double-blind placebo-controlled trial of topiramate treatment for essential tremor , 2002, Neurology.
[47] R. Post,et al. Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders , 2003, Journal of clinical psychopharmacology.
[48] K. Lyons,et al. Essential tremor: differential diagnosis and current therapy. , 2003, The American journal of medicine.
[49] J. Corbo. The role of anticonvulsants in preventive migraine therapy , 2003, Current pain and headache reports.
[50] S. Kochar,et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. , 2004, QJM : monthly journal of the Association of Physicians.
[51] R. Lydiard. The role of GABA in anxiety disorders. , 2003, The Journal of clinical psychiatry.
[52] T. Tchelidze,et al. Bronchial asthma as neurogenic paroxysmal inflammatory disease: a randomized trial with carbamazepine. , 2006, Respiratory medicine.
[53] Conrad C. Huang,et al. PharmGKB Submission Update: IV. PMT Submissions of Genetic Variations in ATP-Binding Cassette Transporters to the PharmGKB Network , 2006, Pharmacological Reviews.
[54] M. Devor,et al. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain , 2005, British journal of pharmacology.
[55] René H. Levy,et al. Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII) , 2007, Epilepsy Research.
[56] A. Harwood,et al. A common mechanism of action for three mood-stabilizing drugs , 2002, Nature.
[57] N. Brunello,et al. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. , 2003, The international journal of neuropsychopharmacology.
[58] Y. Bersudsky. Phenytoin: an anti-bipolar anticonvulsant? , 2006, The international journal of neuropsychopharmacology.
[59] R. Elble,et al. CME Practice Parameter : Therapies for essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2005 .
[60] Jen-Kun Cheng,et al. Mechanisms of the antinociceptive action of gabapentin. , 2006, Journal of pharmacological sciences.
[61] E. Fauman,et al. Pharmacology and mechanism of action of pregabalin: The calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery , 2007, Epilepsy Research.
[62] Piotr Czapiński,et al. Mechanisms of action of antiepileptic drugs. , 2005, Current topics in medicinal chemistry.
[63] D. Hedges,et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. , 2003, The Journal of clinical psychiatry.
[64] Jennie Z Ma,et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial , 2003, The Lancet.
[65] P. Mitchell,et al. Altered gene expression in mice treated with the mood stabilizer sodium valproate. , 2006, The international journal of neuropsychopharmacology.
[66] C. Gundersen,et al. Convergent Effects of Lithium and Valproate on the Expression of Proteins Associated with Large Dense Core Vesicles in NGF-differentiated PC12 Cells , 2004, Neuropsychopharmacology.
[67] M. Guenther,et al. Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.
[68] R. Mutani,et al. Carbamazepine versus diphenylhydantoin in the treatment of myotonia. , 1983, European neurology.
[69] M. Hallett,et al. Confusional syndrome in thalamic stroke , 1984, Neurology.
[70] T. Premkumar,et al. Lamotrigine for schizophrenia. , 2006, The Cochrane database of systematic reviews.
[71] D. Schrump,et al. Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01 , 2006, British Journal of Cancer.
[72] Michael Trimble,et al. Antiepileptic Drugs and the Regulation of Mood and Quality of Life (QOL): The Evidence from Epilepsy , 2005, Epilepsia.
[73] R. Lipton,et al. Epilepsy and migraine , 2003, Epilepsy & Behavior.
[74] C. Norra,et al. Mood disorders and their treatment in patients with epilepsy. , 2005, The Journal of neuropsychiatry and clinical neurosciences.
[75] U. Rudolph,et al. GABA-based therapeutic approaches: GABAA receptor subtype functions. , 2006, Current opinion in pharmacology.
[76] H. Manji,et al. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. , 2001, Psychopharmacology bulletin.
[77] R. Hagan,et al. Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder , 1998, Neuropsychobiology.
[78] R. Belmaker,et al. Phenytoin as an antimanic anticonvulsant: a controlled study. , 2000, The American journal of psychiatry.
[79] M. Bialer. New antiepileptic drugs that are second generation to existing antiepileptic drugs , 2006, Expert opinion on investigational drugs.
[80] Wolfgang Löscher,et al. The neurobiology of antiepileptic drugs , 2004, Nature Reviews Neuroscience.
[81] S. Czuczwar,et al. Non-epilepsy uses of antiepilepsy drugs. , 2006, Pharmacological reports : PR.
[82] T. Tomson,et al. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII) , 2004, Epilepsy Research.
[83] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[84] T. Henry. The history of valproate in clinical neuroscience. , 2003, Psychopharmacology bulletin.
[85] R. Silva,et al. Effects of valproic acid on an animal model of tardive dyskinesia , 2003, Behavioural Brain Research.
[86] G. Breese,et al. Genetic essential tremor in ?-aminobutyric acidA receptor a1 subunit knockout mice , 2005 .
[87] R. Hirschfeld,et al. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders , 2005, Neurology.
[88] P. Goodnick. Anticonvulsants in the treatment of bipolar mania , 2006, Expert opinion on pharmacotherapy.
[89] M. Pollack,et al. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. , 2005, The Journal of clinical psychiatry.
[90] F. Vocci,et al. Pharmacotherapy and other treatments for cocaine abuse and dependence , 2005, Current opinion in psychiatry.
[91] C. Johannessen,et al. Mechanisms of action of valproate: a commentatory , 2000, Neurochemistry International.
[92] M. Rogawski,et al. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist , 2004, Neuropharmacology.
[93] C. Large,et al. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania , 2005, Behavioural Brain Research.
[94] J. Calabrese,et al. Antiepileptic Drugs in Mood‐Disordered Patients , 2005, Epilepsia.
[95] A. Harwood,et al. Search for a common mechanism of mood stabilizers. , 2003, Biochemical pharmacology.
[96] M. Bialer,et al. The antiepileptic and anticancer agent, valproic acid, induces P‐glycoprotein in human tumour cell lines and in rat liver , 2006, British journal of pharmacology.
[97] S. Silberstein. Shared Mechanisms and Comorbidities in Neurologic and Psychiatric Disorders , 2001, Headache.
[98] Shagufta Ahmad,et al. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids , 2005, Epilepsy Research.
[99] G. Rosati,et al. Disfluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam , 2006, Epilepsy & Behavior.
[100] M. Tanabe,et al. Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.
[101] C. Nemeroff,et al. Pharmacology of valproate. , 2003, Psychopharmacology bulletin.
[102] J. Coyle,et al. Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments , 2003, Neuron.
[103] R. Sterzi,et al. Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies , 2005, Neurological Sciences.
[104] R. Belmaker,et al. Valproate decreases inositol biosynthesis , 2004, Biological Psychiatry.
[105] S. Johannessen,et al. Valproate: past, present, and future. , 2006, CNS drug reviews.
[106] G. Sills. The mechanisms of action of gabapentin and pregabalin. , 2006, Current opinion in pharmacology.
[107] S. Watson,et al. Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism? , 2006, The international journal of neuropsychopharmacology.
[108] J. Calabrese,et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. , 2006, The American journal of psychiatry.
[109] R. Hirschfeld,et al. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. , 2003, The Journal of clinical psychiatry.
[110] Richard B. Lipton,et al. Comorbidity of migraine and epilepsy , 1994, Neurology.
[111] R. Malenka,et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[112] M. Bialer,et al. Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. , 2005, Biochemical pharmacology.
[113] L. Willmore,et al. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. , 2003, Brain research. Molecular brain research.
[114] M. Rogawski. Molecular targets versus models for new antiepileptic drug discovery , 2006, Epilepsy Research.
[115] T. Takano,et al. An astrocytic basis of epilepsy , 2005, Nature Medicine.
[116] G. Perugi,et al. Antiepileptic drugs: indications other than epilepsy. , 2004, Epileptic disorders : international epilepsy journal with videotape.
[117] R. Kälviäinen,et al. Visual Field Defects with Vigabatrin , 2001, CNS drugs.
[118] A. Hammer,et al. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy , 2007, Epilepsy & Behavior.
[119] Dawn Carroll,et al. Anticonvulsant drugs for management of pain: a systematic review , 1995, BMJ.
[120] J. Jankovic,et al. Genetic mouse models of essential tremor: are they essential? , 2005, The Journal of clinical investigation.
[121] P. Calabresi,et al. Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro Ischemia , 2006, Stroke.
[122] Ping Zhu,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.
[123] G. Sills,et al. Visual field constriction , 2001, Neurology.
[124] H. Shannon,et al. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats , 2005, Neuropharmacology.
[125] H. Grunze,et al. Neurochemical Underpinnings in Bipolar Disorder and Epilepsy , 2005, Epilepsia.
[126] C. Elger,et al. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? , 2004, Epilepsy & Behavior.
[127] D. Zullino,et al. High-dose tizanidine abuse. , 2003, Psychopharmacology bulletin.
[128] Y. Imamura,et al. Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy. , 1995, The Journal of pharmacology and experimental therapeutics.
[129] R. Belmaker,et al. Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. , 2010, Bipolar disorders.
[130] M. Raja,et al. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. , 2003, The international journal of neuropsychopharmacology.
[131] H. White. Molecular Pharmacology of Topiramate: Managing Seizures and Preventing Migraine , 2005, Headache.
[132] E. Eisenberg,et al. Lamotrigine for neuropathic pain , 2005, Expert review of neurotherapeutics.
[133] W. Löscher. Basic Pharmacology of Valproate , 2002 .
[134] R. McIntyre,et al. Open-Label Adjunctive Topiramate in the Treatment of Unstable Bipolar Disorder , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[135] B. Schmitz. Depression and Mania in Patients with Epilepsy , 2005, Epilepsia.
[136] B. Gronier,et al. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics. , 2005, European journal of pharmacology.
[137] J. Libiger,et al. Antiepileptic drugs in schizophrenia: a review , 2002, European Psychiatry.
[138] M. Devor,et al. Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain , 2005, Neuropharmacology.
[139] E. Laska,et al. Safety and efficacy of γ‐vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction , 2005, Synapse.
[140] P. Keck,et al. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. , 2006, The Journal of clinical psychiatry.
[141] W. Löscher,et al. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions , 2004, Nature Medicine.
[142] J. Calabrese,et al. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder , 2005, Acta psychiatrica Scandinavica. Supplementum.
[143] P. Jobe. Shared Mechanisms of Antidepressant and Antiepileptic Treatments: Drugs and Devices , 2004, Clinical EEG and neuroscience.
[144] P. Schechter,et al. Clinical pharmacology of vigabatrin. , 1989, British journal of clinical pharmacology.
[145] J. Greene,et al. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease , 2006, The Journal of physiology.
[146] S. Silberstein,et al. Topiramate in Migraine Prevention: Results of a Large Controlled Trial , 2004 .
[147] A. Rush,et al. Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. , 2006, Journal of affective disorders.
[148] G. Rosati,et al. Effects of topiramate in patients with cerebellar tremor , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[149] H. J. McQuay,et al. Algorithm for neuropathic pain treatment: An evidence based proposal , 2005, Pain.
[150] J. Coyle,et al. Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis , 2006, Cellular and Molecular Neurobiology.